0A7L Stock Overview
A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
iRhythm Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$130.81 |
| 52 Week High | US$131.84 |
| 52 Week Low | US$56.13 |
| Beta | 1.45 |
| 1 Month Change | 29.97% |
| 3 Month Change | 21.22% |
| 1 Year Change | 20.94% |
| 3 Year Change | 6.08% |
| 5 Year Change | n/a |
| Change since IPO | -16.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0A7L | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 23.4% | 6.4% | 2.2% |
| 1Y | 20.9% | 3.2% | 2.2% |
Return vs Industry: 0A7L exceeded the UK Medical Equipment industry which returned 3.2% over the past year.
Return vs Market: 0A7L exceeded the UK Market which returned 2.2% over the past year.
Price Volatility
| 0A7L volatility | |
|---|---|
| 0A7L Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: 0A7L's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0A7L's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,000 | Quentin Blackford | www.irhythmtech.com |
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
iRhythm Technologies, Inc. Fundamentals Summary
| 0A7L fundamental statistics | |
|---|---|
| Market cap | US$4.19b |
| Earnings (TTM) | -US$98.32m |
| Revenue (TTM) | US$618.59m |
6.8x
P/S Ratio-42.6x
P/E RatioIs 0A7L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0A7L income statement (TTM) | |
|---|---|
| Revenue | US$618.59m |
| Cost of Revenue | US$189.36m |
| Gross Profit | US$429.23m |
| Other Expenses | US$527.55m |
| Earnings | -US$98.32m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.08 |
| Gross Margin | 69.39% |
| Net Profit Margin | -15.89% |
| Debt/Equity Ratio | 746.8% |
How did 0A7L perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/04 20:28 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
iRhythm Technologies, Inc. is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| David Rescott | Baird |
| Joanne Wuensch | BMO Capital Markets Equity Research |